Shingrix shingles vaccine provides 10 years of protection
On October 19, GSK announced that the ZOSTER-049 extension study yielded positive interim results: Shingrix provides at least 10 years of shingles protection in adults
On October 19, GSK announced that the ZOSTER-049 extension study yielded positive interim results: Shingrix provides at least 10 years of shingles protection in adults